Vaxxa AB (FRA:7WA0) Days Payable: 2.77 (As of Mar. 2026) — 96% Below Median


FRA:7WA0 Vaxxa AB FRA:7WA0
23 GF Score
Price €0.03
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Vaxxa AB Days Payable?

Vaxxa AB FRA:7WA0 +3.36% 23 Days Payable is 2.77 as of Mar. 2026, which is 96% below its 10-year median of 62.09. GuruFocus rates FRA:7WA0 with a GF Score™ of 23/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review. Among 2,602 Software companies, Vaxxa AB ranks worse than 98.85% on this metric.

Vaxxa AB's average Accounts Payable for the three months ended in Mar. 2026 was €0.05 Mil. Vaxxa AB's Cost of Goods Sold for the three months ended in Mar. 2026 was €1.53 Mil. Hence, Vaxxa AB's Days Payable for the three months ended in Mar. 2026 was 2.77.

The historical rank and industry rank for Vaxxa AB's Days Payable or its related term are showing as below:

FRA:7WA0' s Days Payable Range Over the Past 10 Years
Min: 0.98   Med: 62.09   Max: 24840.28
Current: 1.64

During the past 10 years, Vaxxa AB's highest Days Payable was 24840.28. The lowest was 0.98. And the median was 62.09.

FRA:7WA0's Days Payable is ranked worse than
98.85% of 2602 companies
in the Software industry
Industry Median: 53.825 vs FRA:7WA0: 1.64

Vaxxa AB's Days Payable declined from Mar. 2025 (3.44) to Mar. 2026 (2.77). It may suggest that Vaxxa AB accelerated paying its suppliers.


Vaxxa AB Days Payable Historical Data

* Premium members only.

The historical data trend for Vaxxa AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxxa AB Days Payable Chart

Vaxxa AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5,840.00 0.96 2.24 2.06

Vaxxa AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.44 0.71 1.08 1.11 2.77

FRA:7WA0 vs UBER, SHOP, CRM: Days Payable Comparison

For the Software - Application subindustry, Vaxxa AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxxa AB Days Payable vs Software Industry

For the Software industry and Technology sector, Vaxxa AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Vaxxa AB's Days Payable falls into.


FRA:7WA0
23GF Score
Vaxxa AB FRA:7WA0
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxxa AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Vaxxa AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.055 + 0.014) / 2 ) / 6.114*365
=0.0345 / 6.114*365
=2.06

Vaxxa AB's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (0.014 + 0.079) / 2 ) / 1.531*365 / 4
=0.0465 / 1.531*365 / 4
=2.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 2.77 mean?
Vaxxa AB (FRA:7WA0) has a Days Payable of 2.77 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vaxxa AB and its competitors. This is 96% below median its historical median of 62.09. Over the past decade, Vaxxa AB's Days Payable has ranged from 0.98 to 24,840.28. According to the industry distribution chart, Vaxxa AB ranks #2572 out of 2602 companies in the Software industry, placing it in the top 98.8%.
Is Vaxxa AB's Days Payable too high?
Vaxxa AB's current Days Payable of 2.77 is 96% below median its 10-year median of 62.09. Over the past 10 years, this metric has ranged from a low of 0.98 to a high of 24,840.28. The Software industry median Days Payable is 53.83. Vaxxa AB's value of 2.77 is 94.9% below this industry median. Based on the distribution chart, Vaxxa AB ranks #2572 out of 2602 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Vaxxa AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's Days Payable compare to UBER and SHOP?
According to the Software industry distribution chart, Vaxxa AB ranks #2572 out of 2602 companies for Days Payable. This places Vaxxa AB in the lower half of its industry. The industry median Days Payable is 53.83. Vaxxa AB's value of 2.77 is 94.9% below this benchmark. Historically, Vaxxa AB's own Days Payable has ranged from 0.98 to 24,840.28 over the past decade. While the company's 10-year median is 62.09 vs. the industry median of 53.83, Vaxxa AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Software company?
The median Days Payable among Software companies is 53.83, based on 2,602 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaxxa AB's current Days Payable of 2.77 is 94.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vaxxa AB and its competitors. For the Software industry, the median Days Payable is 53.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaxxa AB's current Days Payable is 2.77, which is 96% below median its own 10-year median of 62.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Vaxxa AB (FRA:7WA0) has a current Days Payable of 2.77. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 38.4% below its estimated fair value. The current Days Payable is 2.77, which is 96% below median its 10-year median of 62.09 and 94.9% below the Software industry median of 53.83. Vaxxa AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vaxxa AB (FRA:7WA0), the current Days Payable is 2.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxxa AB (FRA:7WA0) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued. The current stock price of €0.03 is trading 38.4% below its estimated GF Value™ of €0.05.

Key valuation signals for FRA:7WA0:

  • Days Payable: 2.77 (96% below median its 10-year median of 62.09)
  • GF Value™: €0.05 vs. price of €0.03 (38.4% below fair value)
  • GF Score™: 23/100 with 2 warning signs
  • Industry Position: 94.9% below the Software median (#2572 of 2602)

No single metric tells the full story. See the FRA:7WA0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vaxxa AB Business Description

Other Exchanges VAXXA:Sweden
Address Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
23GF Score

Get the complete analysis for FRA:7WA0

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.05
GF Value